Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2
Oxidative stress, inflammation, and hypertension constitute a self-perpetuating vicious circle to exacerbate hypertension and subsequent hypertensive cardiac hypertrophy. NADPH oxidase (Nox) 1/4 inhibitor GKT137831 alleviates hypertensive cardiac hypertrophy in models of secondary hypertension; howe...
Main Authors: | Si-yu Zeng, Qiu-jiang Yan, Li Yang, Qing-hua Mei, Hui-qin Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/1078365 |
Similar Items
-
Nox1/4 dual inhibitor GKT137831 attenuates hypertensive cardiac remodelling associating with the inhibition of ADAM17-dependent proinflammatory cytokines-induced signalling pathways in the rats with abdominal artery constriction
by: Si-yu Zeng, et al.
Published: (2019-01-01) -
Evaluating the efficacy and safety of GKT137831 in adults with type 1 diabetes and persistently elevated urinary albumin excretion: a statistical analysis plan
by: Alysha M. De Livera, et al.
Published: (2020-06-01) -
The ERK-cascade in the pathophysiology of cardiac hypertrophy
by: Claßen, Alexandra
Published: (2021) -
b-adrenergic receptors and Erk1/2-mediated cardiac hypertrophy
by: Vidal, Marie
Published: (2013) -
Apocynum Tablet Protects against Cardiac Hypertrophy via Inhibiting AKT and ERK1/2 Phosphorylation after Pressure Overload
by: Jianyong Qi, et al.
Published: (2014-01-01)